AMERISAFE (NASDAQ:AMSF - Get Free Report) will likely be posting its Q2 2025 quarterly earnings results after the market closes on Thursday, July 24th. Analysts expect AMERISAFE to post earnings of $0.55 per share and revenue of $77.30 million for the quarter.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The insurance provider reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.59 by $0.01. AMERISAFE had a net margin of 15.76% and a return on equity of 16.41%. The company had revenue of $83.78 million for the quarter, compared to the consensus estimate of $76.66 million. On average, analysts expect AMERISAFE to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
AMERISAFE Price Performance
NASDAQ:AMSF traded up $0.64 during midday trading on Thursday, hitting $45.65. The company's stock had a trading volume of 142,920 shares, compared to its average volume of 108,746. AMERISAFE has a fifty-two week low of $42.48 and a fifty-two week high of $60.24. The firm's 50 day moving average is $45.34 and its 200-day moving average is $48.51. The firm has a market cap of $869.63 million, a P/E ratio of 18.41 and a beta of 0.40.
AMERISAFE Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 13th were paid a dividend of $0.39 per share. The ex-dividend date was Friday, June 13th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 3.42%. AMERISAFE's payout ratio is 62.90%.
Wall Street Analysts Forecast Growth
Separately, JMP Securities reaffirmed a "market outperform" rating and set a $65.00 price objective on shares of AMERISAFE in a research note on Wednesday, April 30th.
View Our Latest Research Report on AMSF
Institutional Investors Weigh In On AMERISAFE
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Goldman Sachs Group Inc. lifted its position in shares of AMERISAFE by 82.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 217,280 shares of the insurance provider's stock valued at $11,418,000 after buying an additional 98,293 shares in the last quarter. AQR Capital Management LLC lifted its position in shares of AMERISAFE by 5.1% during the 1st quarter. AQR Capital Management LLC now owns 83,478 shares of the insurance provider's stock valued at $4,387,000 after buying an additional 4,050 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of AMERISAFE by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 43,118 shares of the insurance provider's stock valued at $2,266,000 after buying an additional 3,435 shares in the last quarter. Jane Street Group LLC lifted its position in shares of AMERISAFE by 106.8% during the 1st quarter. Jane Street Group LLC now owns 29,176 shares of the insurance provider's stock valued at $1,533,000 after buying an additional 15,070 shares in the last quarter. Finally, Intech Investment Management LLC lifted its position in shares of AMERISAFE by 15.2% during the 1st quarter. Intech Investment Management LLC now owns 21,862 shares of the insurance provider's stock valued at $1,149,000 after buying an additional 2,889 shares in the last quarter. Institutional investors and hedge funds own 97.41% of the company's stock.
About AMERISAFE
(
Get Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Featured Stories

Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.